A Sulfated Proteoglycan as a Novel Ligand for CD44

E-ISSN： 1346-8138|21|11|795-801

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.21, Iss.11, 1994-11, pp. : 795-801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lubricin/Proteoglycan 4 Binding to CD44 Receptor: A Mechanism of the Suppression of Proinflammatory Cytokine–Induced Synoviocyte Proliferation by Lubricin

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 6, 2015-06 ,pp. : 1503-1513

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD44 in Cancer

By Naor David Nedvetzki Shlomo Golan Itshak Melnik Lora Faitelson Yoram

Critical Reviews in Clinical Laboratory Sciences, Vol. 39, Iss. 6, 2002-11 ,pp. : 527-579

Informa Healthcare

Access to resources Recommend Favorite

Expression of Novel CD44st and MMP2 in NSCLC Tissues and Their Clinical Significance

Oncology Research and Treatment, Vol. 40, Iss. 4, 2017-03 ,pp. : 192-196

Karger

Access to resources Recommend Favorite

Severe Congenital Neutropenia or Hyper-IgM Syndrome? A Novel Mutation of CD40 Ligand in a Patient with Severe Neutropenia

International Archives of Allergy and Immunology, Vol. 147, Iss. 3, 2008-07 ,pp. : 255-259

Karger

Access to resources Recommend Favorite

CD44 Expression in Normal Human Skin and Skin Tumors

THE JOURNAL OF DERMATOLOGY, Vol. 22, Iss. 2, 1995-02 ,pp. : 88-94

John Wiley & Sons Inc

Access to resources Recommend Favorite